Market
Alcon stock price change due to Systane recall by March 2025?
2
Resolution / Starting Odds
Increase by more than 10% • 25%
Decrease by more than 10% • 25%
No significant change (+/- 10%) • 25%
Other outcome • 25%
Stock market data from a recognized financial news source
Story
Alcon Recalls One Lot of Systane Eye Drops Nationwide Due to Fungal Contamination, FDA Warns of Vision-Threatening Risks
Dec 26, 2024, 07:01 PM
Systane brand eye drops have been recalled nationwide due to possible fungal contamination, according to an announcement from the Food and Drug Administration (FDA). The recall affects one lot of Systane Lubricant Eye Drops Ultra PF, Single Vials On-the-Go, after a consumer reported finding a foreign material in a sealed vial. Upon investigation, the Texas-based manufacturer, Alcon, confirmed that the material was fungal in nature. The FDA has warned that this contamination could lead to eye infections that may threaten vision, particularly in immunocompromised individuals. The recalled eye drops are commonly used for temporary relief of burning and irritation associated with dry eye symptoms and are sold at retailers including Publix and Amazon. Consumers are advised to check their medicine cabinets for the affected product.
View original story
Similar markets
Product reformulation • 25%
Discontinue product • 25%
No significant changes • 25%
Increased quality checks • 25%
Fine imposed • 25%
Mandatory product reformulation • 25%
No further action • 25%
Temporary production halt • 25%
Recall expanded • 25%
No issues found • 25%
Minor compliance issues • 25%
Major compliance issues • 25%
Switch to alternative brands • 25%
Increased demand for safer packaging • 25%
No significant change • 25%
Decreased trust in Alcon • 25%
Increase by 0-10% • 25%
Decrease by more than 10% • 25%
Increase by more than 10% • 25%
Decrease by 0-10% • 25%
Increases by 0-5% • 25%
Increases by more than 5% • 25%
Decreases by more than 5% • 25%
Decreases by 0-5% • 25%